LIZA WHITACRE: Open Payments
NPI 1922592369 · TEMPERANCE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 105 payments from 16 companies in 2025. Trend: 2023 $1,685 · 2024 $1,582 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $366 |
| ABBVIE INC. | 14 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $184 |
| Novo Nordisk Inc | 13 | $178 |
| GlaxoSmithKline, LLC. | 12 | $162 |
| Axsome Therapeutics, Inc. | 5 | $125 |
| Amgen Inc. | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| PFIZER INC. | 4 | $78 |
| Abbott Laboratories | 4 | $70 |
Products named: AIRSUPRA, CAPLYTA, TRELEGY ELLIPTA, Auvelity, UBRELVY, VRAYLAR, NURTEC ODT, OTEZLA.
Industry payments across MI — which companies pay providers there.
